The Role of MEK-inhibitors for the Prevention and Treatment of Optic Pathway Gliomas in an Nf1 Deficient Mouse Model

syn4939914

Created By Thomas Yu thomas.yu

grantDOI: https://doi.org/10.54464/pc.gr.147654
studyName: The Role of MEK-inhibitors for the Prevention and Treatment of Optic Pathway Gliomas in an Nf1 Deficient Mouse Model
dataStatus: Data Not Expected
initiative: Francis S. Collins Scholars Program
studyLeads: Miriam Bornhorst
studyStatus: Completed
diseaseFocus: Neurofibromatosis type 1
institutions: Children's National
fundingAgency: NTAP
manifestation: Low Grade Glioma
relatedStudies: syn37860391 syn21650395 syn21650488 syn36528589
studyFileviewId: syn15666928
Welcome to the NTAP Prevention and Treatment of Optic Pathway Gliomas Forum
syn34271633
syn15666928

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

The Role of MEK-inhibitors for the Prevention and Treatment of Optic Pathway Gliomas in an Nf1 Deficient Mouse Model

syn4939914

Drop files to upload

The Role of MEK-inhibitors for the Prevention and Treatment of Optic Pathway Gliomas in an Nf1 Deficient Mouse Model page is loading…